Bevacizumab-based therapy and complication risk after colonic stent placement: Is it time for a warning?

Gastrointestinal Endoscopy

Volumn 72, Issue 6, 2010, Pages 1330-

  Fuccio, Lorenzo ^a   Cennamo, Vincenzo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CAPECITABINE; OXALIPLATIN;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; COLON PERFORATION; COLONIC STENT; COLORECTAL CANCER; ENDOSCOPIC THERAPY; GASTROINTESTINAL ENDOSCOPY; HUMAN; LETTER; LOW DRUG DOSE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC DISEASES; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DRUG TOXICITY; FLUOROURACIL; HUMANS; INTESTINAL OBSTRUCTION; INTESTINAL PERFORATION; ORGANOPLATINUM COMPOUNDS; RUPTURE, SPONTANEOUS; STENTS;

EID: 78649493953     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2010.03.1073     Document Type: Letter

References (3)

1. A.J. Small, N. Coelho-Prabhu, and T.H. Baron Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors Gastrointest Endosc 71 2010 560 572
2. V. Cennamo, L. Fuccio, and V. Mutri Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? Clin Gastroenterol Hepatol 7 2009 1174 1176
3. Y. Cao, A. Tan, and F. Gao A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer Int J Colorectal Dis 24 2009 677 685